Eric Yoon

• Represented a dental supply company in private and public antirust actions – individual, class action and the Federal Trade Commission (FTC) Part III Administrative Hearing – and governmental investigations

• Represented a trust company in a proposed class action on the basis of breach of fiduciary claims under the Employee Retirement Income Security Act of 1974 (ERISA) and a civil conspiracy under the Racketeer Influenced and Corrupt Organizations Act (RICO)
• Represented a major insurance company in a proposed class action involving the insurer's reserves and surplus
• Successfully defended several financial institutions against putative shareholder class action lawsuits challenging proposed mergers of those financial institutions

• Represented employers and high-level executives in employment litigation matters involving allegations of sexual harassment, discrimination, retaliation, wrongful termination and breach of employment contract
• Representing employers in restrictive covenant disputes, trade secret litigation, computer fraud and abuse matters, and unfair competition claims

• Represented several national banks on various lender liability, Telephone Consumer Protection Act (TCPA) and Fair Credit Reporting Act (FCRA) matters

• Corporate IP Counseling (Ballistics): Lead counsel for a foreign consumer products company on international transfer and protection of intellectual property rights, corporate formation and funding, immigration and federal government contracts.
• Citizen Petition (Transdermal Patch and Therapy): Lead counsel for a pharmaceutical company on the filing of a Citizen Petition with FDA concerning dose proportionality requirements for approval of generic and 505(b)(2) applications to a branded transdermal patch.
• Launch "At Risk" Patent Counseling (Opioid Antagonist): Lead counsel for pharmaceutical company on analysis of, and a decision concerning, a potential launch-at-risk of its generic product.  
• Corporate IP Counseling (Oncogenetic Biomedicines): Counseled client, including as lead counsel, on numerous joint development, research and material transfer agreements concerning multiple oncogenetic biomedicines.
• Patent Prosecution (Transdermal Device and Therapy): Lead counsel for a biotechnology company on the filing of a pharmaceutical patent application for a transdermal device and therapy.
• Patent Opinion Counseling (Branded Immuno-adjuvant Therapy): Represented branded pharmaceutical company on freedom to operate opinion concerning immuno-adjuvant technologies and therapies.*
• Patent Litigation Counseling (Branded Nanoparticle Oncologic): Advised branded pharmaceutical company concerning the strengths and weaknesses of the litigants' case in an ongoing pharmaceutical patent litigation, where the client held a vested interest.*
• False Advertising and Trademark Infringement Counseling (Seed Science): Counseled agribusiness client concerning investigation of potential false advertising and trademark infringement.*
• Patent Counseling (Patent Law of the Sea): Advised oil company concerning jurisdictional reach of U.S. patent law to various depths and distances of the ocean from the mainland.*

* Matter handled prior to joining Holland & Knight